Harel Insurance Investments & Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
RJA
PFS
Harel Insurance Investments & Financial Services's SBIO Position: Q4 2016 in Review
Harel Insurance Investments & Financial Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2016, closing a stake of 1,070 shares — an estimated $28K sold.
Harel Insurance Investments & Financial Services first reported a position in SBIO in Q4 2015 and held it in 4 quarters. The position peaked at $79K in Q4 2015. 26 funds tracked by Wall St. Rank hold SBIO as of Q4 2016.
- Harel Insurance Investments & Financial Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2016 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 1,070 ALPS Medical Breakthroughs ETF shares in Q4 2016, an estimated $28K.
- Harel Insurance Investments & Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 4 quarters.
- Harel Insurance Investments & Financial Services's ALPS Medical Breakthroughs ETF position peaked at $79K in Q4 2015.
- 26 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2016.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.